Cited by 46NF-κB Signaling PathwaysProtein Kinase Regulation and GTPase SignalingAdipose Tissue and Metabolism

Defining the role of DAG, mitochondrial function, and lipid deposition in palmitate-induced proinflammatory signaling and its counter-modulation by palmitoleate

Open access
Macrae, Katherine, Stretton, Clare, Lipina, Christopher, Blachnio-Zabielska, Agnieszka, Baranowski, Marcin, Gorski, Jan, Marley, Anna, Hundal, Harinder S.·2013·Journal of Lipid Research

Abstract

Chronic exposure of skeletal muscle to saturated fatty acids, such as palmitate (C16:0), enhances proinflammatory IKK-NFκB signaling by a mechanism involving the MAP kinase (Raf-MEK-ERK) pathway. Raf activation can be induced by its dissociation from the Raf-kinase inhibitor protein (RKIP) by diacylglycerol (DAG)-sensitive protein kinase C (PKC). However, whether these molecules mediate the proinflammatory action of palmitate, an important precursor for DAG synthesis, is currently unknown. Here, involvement of DAG-sensitive PKCs, RKIP, and the structurally related monounsaturated fatty acid palmitoleate (C16:1) on proinflammatory signaling are investigated. Palmitate, but not palmitoleate, induced phosphorylation/activation of the MEK-ERK-IKK axis and proinflammatory cytokine (IL-6, CINC-1) expression. Palmitate increased intramyocellular DAG and invoked PKC-dependent RKIP(Ser153) phosphorylation, resulting in RKIP-Raf1 dissociation and MEK-ERK signaling. These responses were mimicked by PMA, a DAG mimetic and PKC activator. However, while pharmacological inhibition of PKC suppressed PMA-induced activation of MEK-ERK-IKK signaling, activation by palmitate was upheld, suggesting that DAG-sensitive PKC and RKIP were dispensable for palmitate's proinflammatory action. Strikingly, the proinflammatory effect of palmitate was potently repressed by palmitoleate. This repression was not due to reduced palmitate uptake but linked to increased neutral lipid storage and enhanced cellular oxidative capacity brought about by palmitoleate's ability to restrain palmitate-induced mitochondrial dysfunction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m036996

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Macrae, K., Stretton, C., Lipina, C., Blachnio-Zabielska, A., Baranowski, M., Gorski, J., Marley, A., & Hundal, H. S.
Affiliations
  • University of Dundee (GB)
  • Medical University of Białystok (PL)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Hundal, Harinder S.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2013-09
Volume
54
Issue
9
Pages
2366-2378
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2134785944
Cited by
46
References
63
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 3 · 2020: 6 · 2019: 3 · 2017: 7 · 2016: 4 · 2015: 9 · 2014: 4
FWCI
1.99
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • AstraZeneca
  • Diabetes UK (10/0004045)
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
palmitate, palmitoleic acid, diacylglycerol, protein kinase C, RKIP, MAPK/ERK pathway, skeletal muscle inflammation, saturated fatty acids, monounsaturated fatty acids, mitochondrial dysfunction, oxidative capacity, inflammatory cytokines, interleukin-6, CINC-1, PMA, fatty acid uptake
MeSH terms
Animals, Biological Transport, Cell Line, Diglycerides, Fatty Acids, Monounsaturated, Inflammation, Mitochondria, Oxygen, Palmitates, Phosphorylation, Protein Kinase C, Signal Transduction, Proto-Oncogene Proteins c-raf, Extracellular Signal-Regulated MAP Kinases, Phosphatidylethanolamine Binding Protein, Rats, I-kappa B Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review